Prescient Therapeutics Ltd (ASX:PTX)
APAC company
Share Price Chart
- Chart currently unavailable -
Market Info - PTX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - PTX
- Market CapAUD0.000m
- SymbolASX:PTX
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINAU000000PTX3
Company Profile
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.Prescient Therapeutics Ltd is a clinical stage oncology company engaged in developing & commercialising novel products to improve standard cancer treatments.
Latest PTX news
Currently there for this company. Visit our news hub for other news .